Orsini Healthcare

What Orsini Healthcare does

Orsini Healthcare is a US specialty pharmacy founded in 1987 and headquartered in Elk Grove Village, Illinois, with a secondary site in Columbus, Ohio. The company focuses on rare disease and complex therapy programs, including cell and gene therapies, operating under a 'No Patient Left Behind' care philosophy. Orsini serves four primary stakeholder groups: patients with rare diseases, healthcare providers prescribing specialty therapies, biopharma manufacturers requiring distribution partners, and payors covering high-cost medications.

The company is built around five integrated service modules: a core Specialty Pharmacy service for medication management and distribution; a Patient Services Hub providing benefits verification, prior authorizations, financial assistance, and care coordination; Third-Party Logistics for temperature-controlled distribution of sensitive therapies; Home Infusion & Nursing for in-home administration; and ORBIT Technology & Real World Data, a proprietary platform for tracking patient outcomes and generating real-world evidence. Orsini holds six concurrent accreditations (URAC Mail Services, URAC Rare Disease Center of Excellence, URAC Specialty Pharmacy, ACHC, ACHC Orphan Drug, NABP) and Legitscript verification, all valid through 2027.

The business model is sales-led and enterprise-contract based, generating revenue primarily through contracted specialty pharmacy relationships with biopharma manufacturers, with disclosed exclusive partnerships with Gilead Sciences (for Hepcludex in hepatitis D) and Denali Therapeutics (for the investigational AVLAYAH gene therapy). Patient-level services are billed through insurance with variable copays. The company employs 251-500 people and operates exclusively in the US market. Recent strategic activity in 2025-2026 — two new biopharma partnerships and a senior HR leadership appointment — indicates an active expansion phase.

Name

Orsini Healthcare

Legal name

Orsini

Website

https://orsinispecialtypharmacy.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

251–500 employees

Short description

Orsini Healthcare is a US specialty pharmacy founded in 1987 that dispenses rare disease and cell/gene therapies, operating as a contracted distribution partner for biopharma manufacturers with integrated services including patient hub, home infusion, cold-chain logistics, and real-world data.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Health Services (8000)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Specialty pharmacy services
• Rare disease pharmacy
• Cell and gene therapy
• Home infusion services
• Patient hub services

Headquarters

HQ city

Elk Grove Village

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Services: Specialty pharmacy services providing rare disease and complex therapy medications to patients, operating as a contracted pharmacy partner for biopharma manufacturers.
2. Patient Services Hub: Comprehensive patient support services including care coordination, adherence programs, and financial assistance for rare disease patients.
3. Third-Party Logistics: Specialized logistics and distribution services for specialty medications requiring temperature control and chain of custody management.
4. Home Infusion & Nursing: In-home infusion therapy administration and nursing services for patients receiving specialty medications.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Orsini Healthcare is a specialty pharmacy that dispenses, distributes, and supports rare disease, cell, and gene therapy medications for patients, healthcare providers, biopharma manufacturers, and payors. Its offering combines core mail-order specialty pharmacy dispensing with a Patient Services Hub, temperature-controlled third-party logistics, home infusion and nursing, and the ORBIT real-world data technology platform to deliver end-to-end therapy support.

Product overview

Orsini is a specialty pharmacy solutions provider focused on rare disease and complex therapy programs, operating as a unified platform with five integrated service modules. The core Specialty Pharmacy service forms the foundation, supported by the Patient Services Hub for care coordination, Third-Party Logistics for supply chain management, Home Infusion & Nursing for in-home care delivery, and ORBIT Technology & Real World Data for analytics and outcomes tracking. Together, these modules create an end-to-end solution for biopharma companies, healthcare providers, patients, and payors managing rare disease and gene therapy treatments.

Differentiator

Problem solved

Functional benefit

Brands

• ORBIT Technology & Real World Data: Technology platform and real world data solution offered by Orsini for tracking and analyzing patient outcomes.

Products and services

• Specialty Pharmacy Core mail-order specialty pharmacy service providing comprehensive medication management and distribution for rare disease and complex therapy patients, including specialty medications, clinical support, and patient monitoring.
• Patient Services Hub Centralized hub coordinating patient support services including benefits verification, prior authorizations, financial assistance, and ongoing care coordination to ensure patients receive continuous support throughout their treatment journey.
• Third-Party Logistics Specialized logistics services for handling and distributing temperature-sensitive, rare disease medications and gene therapies, ensuring secure and timely delivery to patients and healthcare providers.
• Home Infusion & Nursing Comprehensive home-based infusion therapy services with registered nurses providing in-home patient assessment, medication administration, and ongoing monitoring for patients receiving injectable or infusion therapies.
• ORBIT Technology & Real World Data Proprietary technology platform and real world data system that tracks patient outcomes, therapy effectiveness, and healthcare utilization to support evidence-based care decisions and improve patient outcomes.

Quantifiable outcome

• Comprehensive care for rare disease patients since 1987

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Denali TherapeuticscoreStrategic or Co-development Partner · 20 April 2026Orsini Healthcare was selected as the exclusive specialty pharmacy and home infusion partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm), an investigational therapy. This represents a flagship exclusive partnership for distribution and patient support services for this rare disease treatment.
• Gilead SciencescoreStrategic or Co-development Partner · 26 May 2025Orsini Healthcare serves as a contracted specialty pharmacy partner for Gilead Sciences' Hepcludex® (bulevirtide-gmod), a treatment for hepatitis D delta virus. This partnership enables Orsini to dispense and manage this specialty medication for eligible patients.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Accredo (Evernorth/Express Scripts): Accredo is the largest US specialty pharmacy, owned by Cigna's Evernorth, dispensing across rare disease, oncology, and cell/gene therapy. It competes head-to-head with Orsini for biopharma distribution mandates and serves the same patient, provider, and payer ecosystem.
• CVS Specialty Pharmacy: CVS Specialty is the specialty pharmacy arm of CVS Health, distributing high-cost and complex therapies nationally. It overlaps with Orsini across rare disease therapy fulfillment and is a frequent competing bidder for exclusive biopharma contracts.
• Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy provides nationwide specialty medication fulfillment, including for rare and chronic conditions. It competes directly with Orsini on biopharma contracts and shares the same mail-order specialty dispensing model.
• Optum Specialty Pharmacy (formerly Diplomat): Optum Specialty Pharmacy (built on Diplomat) operates within UnitedHealth Group and dispenses specialty and rare disease therapies. It is a direct competitor for biopharma distribution and patient hub services, particularly for cell/gene therapy.
• CenterWell Specialty Pharmacy (Humana): CenterWell Specialty Pharmacy is Humana's specialty pharmacy arm, dispensing complex and high-cost medications for chronic and rare conditions. It competes with Orsini in the payer-aligned specialty pharmacy space.

Direct peers

• Biologics by McKesson: Biologics by McKesson is a specialty pharmacy focused on oncology and complex therapeutics with biopharma services and patient support programs. It mirrors Orsini's contract pharmacy and patient hub model for high-cost specialty medications.
• US Bioservices (AmerisourceBergen / Cencora): US Bioservices is Cencora's specialty pharmacy serving patients with rare, chronic, and complex conditions, including limited distribution drugs. It competes with Orsini for exclusive limited distribution drug contracts with biopharma manufacturers.
• PantherRx Rare: PantherRx Rare is a specialty pharmacy exclusively focused on rare and orphan disease therapies, providing dispensing, patient support, and limited distribution services. It is one of Orsini's closest niche competitors in the rare disease specialty pharmacy segment.
• Amber Specialty Pharmacy: Amber Specialty Pharmacy is a Hy-Vee-owned specialty pharmacy providing nationwide fulfillment and clinical management for chronic and rare conditions. It competes with Orsini for biopharma contracts and serves overlapping therapeutic areas.

Emerging players

• Kroger Specialty Pharmacy: Kroger Specialty Pharmacy provides specialty medication fulfillment and clinical support, often tied to Kroger's retail pharmacy footprint. It is a smaller but growing competitor to Orsini's mail-order specialty dispensing model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/OrsiniSpecialty
• Facebookfacebook.com/orsinispecialtypharmacy

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orsini Healthcare